The BEAM Alliance The Beam Alliance fully supports Jim O’Neill’s Comprehensive Plan to Combat Superbugs!
19 May 2016. The BEAM Alliance The Beam Alliance fully supports Jim O’Neill’s Comprehensive Plan to Combat Superbugs! Biotech companies such as members of the BEAM Alliance are strongly supportive of the vision and pragmatic solutions proposed by the UK Review on AMR. It is the first time such a thorough global economic analysis on the threat on AMR with long-time projections is published. We, as actors of innovation in the field, face every day the funding needs, path to market and other healthcare payers issues well raised by the Jim O’Neil team, which limit and even sometimes prevent us from translating potential great innovative ideas to products on the market. The Global Innovation Fund, Market entry and Diagnostic Rewards, the promotion of novel alternative and preventives solutions, and overall better rewards to innovation by National healthcare purchase and distribution systems on AMR solutions, are all ambitious but required actions to radically change the current crisis situation.
We are hopeful that worldwide leaders will not only acknowledge conclusions of this report, but actually decide to join forces and act now to win the battle against resistance to antibiotics. Read the press release and the full report for the action plan.